Want to see IN:AJANTPHARM full AI Analyst Report?
Ajanta Pharma Limited (AJANTPHARM) Ratios
Ajanta Pharma Limited Ratios
IN:AJANTPHARM's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:AJANTPHARM's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.64 | 2.85 | 3.05 | 2.49 | 3.50 |
| Quick Ratio | 1.98 | 1.95 | 2.12 | 1.77 | 2.28 |
| Cash Ratio | 0.07 | 0.18 | 0.14 | 0.29 | 0.32 |
| Solvency Ratio | 0.76 | 0.87 | 0.89 | 0.56 | 1.06 |
| Operating Cash Flow Ratio | 0.36 | 1.16 | 0.88 | 0.69 | 0.87 |
| Short-Term Operating Cash Flow Coverage | 2.44 | 446.81 | 526.89 | 4398.78 | 2081.63 |
| Net Current Asset Value | $ 21.08B | $ 16.18B | $ 16.60B | $ 15.43B | $ 14.73B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.06 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.05 | 0.01 | 0.01 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.36 | 1.32 | 1.30 | 1.38 | 1.24 |
| Debt Service Coverage Ratio | 5.46 | 46.54 | 110.20 | 120.29 | 80.96 |
| Interest Coverage Ratio | 82.23 | 54.44 | 272.92 | 121.76 | 76.63 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 22.12 | 5.44 | 3.37 | 3.24 | 2.72 |
| Net Debt to EBITDA | 0.10 | -0.10 | -0.07 | -0.33 | -0.17 |
| Profitability Margins | |||||
| Gross Profit Margin | 51.44% | 75.43% | 73.50% | 70.34% | 73.00% |
| EBIT Margin | 25.56% | 26.37% | 26.64% | 20.07% | 28.00% |
| EBITDA Margin | 28.74% | 29.51% | 29.86% | 23.55% | 31.80% |
| Operating Profit Margin | 24.29% | 24.60% | 46.75% | 19.00% | 23.80% |
| Pretax Profit Margin | 25.26% | 25.92% | 26.47% | 19.91% | 27.69% |
| Net Profit Margin | 19.37% | 20.06% | 19.39% | 15.71% | 21.70% |
| Continuous Operations Profit Margin | 19.37% | 20.06% | 19.39% | 15.71% | 21.70% |
| Net Income Per EBT | 76.65% | 77.40% | 73.27% | 78.90% | 78.36% |
| EBT Per EBIT | 103.99% | 105.38% | 56.61% | 104.81% | 116.36% |
| Return on Assets (ROA) | 17.16% | 18.35% | 17.60% | 12.57% | 17.57% |
| Return on Equity (ROE) | 23.33% | 24.28% | 22.88% | 17.35% | 21.83% |
| Return on Capital Employed (ROCE) | 27.95% | 28.08% | 52.58% | 20.09% | 22.93% |
| Return on Invested Capital (ROIC) | 20.47% | 21.66% | 38.40% | 15.81% | 17.94% |
| Return on Tangible Assets | 17.27% | 18.52% | 17.65% | 12.59% | 17.61% |
| Earnings Yield | 3.01% | 2.81% | 2.90% | 3.80% | 4.55% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.94 | 3.88 | 3.38 | 3.54 | 3.22 |
| Payables Turnover | 4.87 | 2.48 | 2.41 | 2.63 | 2.71 |
| Inventory Turnover | 2.82 | 1.25 | 1.35 | 1.36 | 1.12 |
| Fixed Asset Turnover | 2.62 | 2.42 | 2.45 | 2.20 | 1.99 |
| Asset Turnover | 0.89 | 0.91 | 0.91 | 0.80 | 0.81 |
| Working Capital Turnover Ratio | 2.62 | 2.49 | 2.38 | 2.26 | 2.19 |
| Cash Conversion Cycle | 178.55 | 239.71 | 227.63 | 232.23 | 304.30 |
| Days of Sales Outstanding | 124.21 | 94.10 | 108.13 | 103.07 | 113.34 |
| Days of Inventory Outstanding | 129.37 | 292.69 | 271.09 | 268.15 | 325.63 |
| Days of Payables Outstanding | 75.02 | 147.08 | 151.59 | 138.99 | 134.67 |
| Operating Cycle | 253.57 | 386.79 | 379.22 | 371.23 | 438.97 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 41.34 | 92.45 | 62.35 | 61.80 | 43.35 |
| Free Cash Flow Per Share | 12.11 | 67.05 | 50.24 | 48.18 | 31.87 |
| Dividend Paid and CapEx Coverage Ratio | 0.72 | 1.73 | 0.99 | 3.00 | 2.43 |
| Capital Expenditure Coverage Ratio | 1.41 | 3.64 | 5.15 | 4.54 | 3.78 |
| Operating Cash Flow Coverage Ratio | 1.98 | 24.40 | 22.25 | 22.22 | 22.45 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.25 | 0.19 | 0.21 | 0.17 |
| Free Cash Flow Yield | 0.43% | 2.56% | 2.24% | 3.99% | 2.64% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 33.18 | 35.58 | 34.54 | 26.34 | 21.96 |
| Price-to-Sales (P/S) Ratio | 6.43 | 7.14 | 6.70 | 4.14 | 4.77 |
| Price-to-Book (P/B) Ratio | 7.74 | 8.64 | 7.90 | 4.57 | 4.79 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 231.72 | 39.04 | 44.55 | 25.09 | 37.88 |
| Price-to-Operating Cash Flow Ratio | 67.86 | 28.31 | 35.90 | 19.56 | 27.85 |
| Price-to-Earnings Growth (PEG) Ratio | 2.23 | 2.64 | 0.84 | -1.59 | 2.24 |
| Enterprise Value Multiple | 22.46 | 24.10 | 22.36 | 17.24 | 14.81 |
| Enterprise Value | 351.98B | 326.34B | 280.93B | 151.93B | 154.71B |
| EV to EBITDA | 22.46 | 24.10 | 22.36 | 17.24 | 14.81 |
| EV to Sales | 6.46 | 7.11 | 6.68 | 4.06 | 4.71 |
| EV to Free Cash Flow | 232.75 | 38.88 | 44.41 | 24.61 | 37.44 |
| EV to Operating Cash Flow | 68.16 | 28.20 | 35.78 | 19.19 | 27.53 |
| Tangible Book Value Per Share | 359.05 | 299.09 | 282.15 | 263.84 | 251.07 |
| Shareholders’ Equity Per Share | 362.38 | 302.81 | 283.31 | 264.44 | 251.77 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.23 | 0.27 | 0.21 | 0.22 |
| Revenue Per Share | 436.49 | 366.50 | 334.25 | 292.12 | 253.29 |
| Net Income Per Share | 84.53 | 73.53 | 64.82 | 45.89 | 54.97 |
| Tax Burden | 0.77 | 0.77 | 0.73 | 0.79 | 0.78 |
| Interest Burden | 0.99 | 0.98 | 0.99 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.05 | 0.06 | 0.06 |
| SG&A to Revenue | 0.23 | 0.24 | 0.03 | 0.21 | 0.20 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.49 | 1.26 | 0.96 | 1.06 | 0.62 |
Currency in INR
